NBY  Novabay Pharmaceuticals Inc.

Exchange

AMEX

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

8.71M

Vuru Grade

31.66/100

Current Price

$2.50
+0.13 (+5.57%)

Company Metrics

  • P/E 0
  • P/S 2.55
  • P/B 31.16
  • EPS -7.93
  • Cash ROIC 921.20%
  • Cash Ratio 0.51
  • Dividend 0 / N/A %
  • Avg. Vol. 25,923.00
  • Shares 2.78M
  • Market Cap. 8.71M

Company Description

NovaBay Pharmaceuticals Inc., a clinical stage biotechnology company, engages in developing proprietary and patented topical Aganocide compounds for the treatment and prevention of various infections without causing bacterial resistance. Its Aganocide compounds are synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white bloo... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

NovaBay Says Its Avenova Cuts Bacteria On Ocular Skin Surface By Over 90%
Benzinga - May 3, 2016
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) revealed the presentation of clinical data demonstrating that its Avenova reduced the bacterial load on the ocular skin surface by over 90 percent in 20 minutes without affecting the diversity in the remaining ...
NovaBay Pharmaceuticals Inc.
MarketWatch - Jul 16, 2010
NovaBay Pharmaceuticals Inc. NYSE MKT: NBY. GO. Set Alerts · Find a Broker · Join TD Ameritrade · Market Index · Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
News NovaBay Pharmaceuticals Inc.NBY
Wall Street Journal - Feb 11, 2011
News NovaBay Pharmaceuticals Inc.NBY. Significant News Only. 5 hours ago; Press Release. Clinical Data Presented at ARVO Showing NovaBay's Avenova Reduces Bacteria on Ocular Skin Surface by More than 90%.
Zacks: NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Receives Consensus ...
Web Breaking News - 2 hours ago
NovaBay Pharmaceuticals logo NovaBay Pharmaceuticals, Inc. (NYSE:NBY) has earned an average broker rating score of 3.00 (Hold) from the one analysts that provide coverage for the stock, Zacks Investment Research reports.
NovaBay Pharmaceuticals Sheds 12% After Presentation of Data Showing Avenova ...
Sonoran Weekly Review - 20 hours ago
NovaBay Pharmaceuticals (NYSEMKT:NBY) drops 12% after the company said clinical data were presented showing Avenova reduced the bacterial load on the ocular skin surface by more than 90% in 20 minutes without affecting the diversity in the type of ...
Zacks: NovaBay Pharmaceuticals, Inc. (NYSE:NBY) Receives Consensus ...
The Vista Voice - Apr 16, 2016
NovaBay Pharmaceuticals logo NovaBay Pharmaceuticals, Inc. (NYSE:NBY) has been given a consensus broker rating score of 3.00 (Hold) from the one analysts that cover the stock, Zacks Investment Research reports.
NovaBay Pharmaceuticals, Inc. (NBY) Sees Significant Growth in Short Interest - Web Breaking News
NovaBay Pharmaceuticals, Inc. (NBY) Short Interest Up 41.9% in March
The Vista Voice - Apr 11, 2016
NovaBay Pharmaceuticals logo NovaBay Pharmaceuticals, Inc. (NYSE:NBY) was the target of a large growth in short interest in March.
NovaBay Pharmaceuticals, Inc. (NBY) Earns Hold Rating from Maxim Group - Mas Market News
NovaBay Pharmaceuticals, Inc. (NBY) Stock Rating Reaffirmed by Maxim Group
The Vista Voice - Apr 7, 2016
NovaBay Pharmaceuticals, Inc. (NYSE:NBY)'s stock had its “hold” rating reissued by investment analysts at Maxim Group in a research note issued on Wednesday, MarketBeat Ratings reports.
New Analyst Ratings On NovaBay Pharmaceuticals, Inc. (NBY) - Risers & Fallers
Novabay Pharmaceuticals Incorporated (NYSEMKT:NBY) Sellers Increased By 1.45 ...
Franklin Independent - May 2, 2016
NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., is a biopharmaceutical company, which develops products for the eye care market.
After Today's Huge Decline, Is NovaBay Pharmaceuticals, Inc.'s Near-Term ... - B.O.D.Y Confidential
Active Watch List: NovaBay Pharmaceuticals (NYSEMKT:NBY), Medivation (NASDAQ ... - KC Register
How Analysts Feel About NovaBay Pharmaceuticals, Inc. After Today's Huge Increase?
Franklin Independent - Apr 30, 2016
The stock of NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) is a huge mover today! The stock increased 15.01% or $0.41 on April 29, hitting $3.16.